275 related articles for article (PubMed ID: 15988912)
1. Telomerase as a target for cancer therapy.
Parkinson KE
Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
[TBL] [Abstract][Full Text] [Related]
2. Anticancer therapy targeting telomeres and telomerase : current status.
Parkinson EK; Minty F
BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
4. [Telomere and telomerase in human cancer].
Hiyama K; Hiyama E; Ishioka S; Yamakido M
Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
[TBL] [Abstract][Full Text] [Related]
5. Telomerase inhibitors in cancer therapy: current status and future directions.
Incles CM; Schultes CM; Neidle S
Curr Opin Investig Drugs; 2003 Jun; 4(6):675-85. PubMed ID: 12901225
[TBL] [Abstract][Full Text] [Related]
6. Telomeres and telomerase as targets for anticancer drug development.
Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
[TBL] [Abstract][Full Text] [Related]
7. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects.
Kelland LR
Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745
[TBL] [Abstract][Full Text] [Related]
8. Telomerase as a new target for pancreatic cancer treatment.
Sato N; Mizumoto K; Nagai E; Tanaka M
J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
[TBL] [Abstract][Full Text] [Related]
9. The telomeric PARP, tankyrases, as targets for cancer therapy.
Seimiya H
Br J Cancer; 2006 Feb; 94(3):341-5. PubMed ID: 16421589
[TBL] [Abstract][Full Text] [Related]
10. Targeting telomeres and telomerase.
De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
[TBL] [Abstract][Full Text] [Related]
11. Targeting the limitless replicative potential of cancer: the telomerase/telomere pathway.
Kelland L
Clin Cancer Res; 2007 Sep; 13(17):4960-3. PubMed ID: 17785545
[TBL] [Abstract][Full Text] [Related]
12. Telomere biology of pediatric cancer.
Tabori U; Dome JS
Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
[TBL] [Abstract][Full Text] [Related]
13. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
[TBL] [Abstract][Full Text] [Related]
14. Telomere-based cancer treatment: emerging targeted therapies.
Chen M; McLeskey SW
Clin J Oncol Nurs; 2010 Dec; 14(6):720-6. PubMed ID: 21112850
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibitors.
Rowley PT; Tabler M
Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
[TBL] [Abstract][Full Text] [Related]
16. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
Philippi C; Loretz B; Schaefer UF; Lehr CM
J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
[TBL] [Abstract][Full Text] [Related]
17. Telomerase inhibition, oligonucleotides, and clinical trials.
Corey DR
Oncogene; 2002 Jan; 21(4):631-7. PubMed ID: 11850789
[TBL] [Abstract][Full Text] [Related]
18. Telomerase as a diagnostic and therapeutic target for cancer.
Doyle LA; Highsmith WE
Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
[TBL] [Abstract][Full Text] [Related]
19. Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies.
Keith WN; Bilsland A; Hardie M; Evans TR
Nat Clin Pract Oncol; 2004 Dec; 1(2):88-96. PubMed ID: 16264826
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
Rankin AM; Faller DV; Spanjaard RA
Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]